propranolol has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brazzolotto, X; Colletier, JP; Coquelle, N; Gobec, S; Jukič, M; Knez, D; Kos, J; Mravljak, J; Nachon, F; Pišlar, A; Sova, M; Žakelj, S | 1 |
| Buxser, SE; Decker, DE; Horwitz, LD; Wallner, JS | 1 |
2 other study(ies) available for propranolol and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Caco-2 Cells; Cell Line, Tumor; Cholinesterase Inhibitors; Drug Design; Humans; Ligands; Models, Molecular; Neuroprotective Agents; Piperidines | 2018 |
Efficacy of lipid soluble, membrane-protective agents against hydrogen peroxide cytotoxicity in cardiac myocytes.
Topics: Animals; Antioxidants; Cell Death; Cell Membrane; Cells, Cultured; Chick Embryo; Chromans; Diltiazem; Dose-Response Relationship, Drug; Free Radical Scavengers; Hydrogen Peroxide; Kinetics; L-Lactate Dehydrogenase; Lidocaine; Lipid Peroxidation; Lipids; Pregnatrienes; Probucol; Propranolol; Solubility | 1996 |